News & articles
Serving Global Skincare BrandsHow Radiptide supports global skincare brands with export-ready peptide supply.
About RadiptideRadiptide is a trusted Beauty Peptide factory focused on R&D, production and supply of high-purity cosmetic peptides.
- Who We Are
High Purity & QualityEvery batch reaches ≥98% purity, verified by HPLC and mass spectrometry before release.Scalable ProductionFrom R&D samples to bulk commercial supply — consistent quality at any order volume.Fast Global DeliveryIn-stock peptides ship within 1–3 business days. Cus
Our Manufacturing FacilityRadiptide operates a GMP-aligned synthesis and testing facility in Guangzhou. From raw material intake through SPPS synthesis, multi-column HPLC purification, lyophilization and nitrogen-sealed packaging, every step is documented and traceable.We support catalog cosmetic peptides and custom se
Global ReachWe proudly supply cosmetic peptide raw materials to partners in 35+ countries and regions worldwide — from independent skincare brands and ODM manufacturers to ingredient distributors building long-term product lines.Our export team supports international shipping, English-language technic
Snap-8Anti-wrinkle octapeptide modulating SNARE complex activity. Peptide-based alternative for expression line reduction.
FDA Approves MIMRYLO (Rusfertide), a Hepcidin-Mimetic Peptide for Polycythemia VeraThe FDA approved rusfertide (MIMRYLO) on August 28, 2026 for polycythemia vera patients needing frequent phlebotomy—marking the first hepcidin-mimetic peptide therapy in the United States.
- FDA Advisory Panel Backs Six Peptides for 503A Bulks-List Consideration
The FDA Pharmacy Compounding Advisory Committee recommended six peptide bulk substances for 503A list consideration after two days of safety, sourcing, and dosing testimony in July 2026.
- Solvent Recovery and Waste-Intensity Metrics Enter Peptide Supplier Scorecards
Peptide suppliers face new scorecard metrics on solvent recovery and waste intensity in 2026.
- Empowering small and medium-sized beauty enterprises, peptide factories become industry development
Empowering small and medium-sized beauty enterprises: how peptide factories support industry development.
- Matrixyl and Argireline Peptides Re-enter Mass-Market Anti-Wrinkle Pipelines
Classic Matrixyl and Argireline peptides return to mass-market anti-wrinkle launches in 2026.
- Is it difficult to find high-quality peptide raw materials? Professional peptide factory unlocks new
Professional peptide factory: unlocking new heights in skincare ingredients.
- Where can I find high-quality peptide raw materials? Professional peptide factory injects core power
Where to find high-quality peptide raw materials for skincare.
- Cosmetic Buyers Adopt Research-Grade Release Criteria for Peptide Raw Materials
Cosmetic buyers tighten peptide release criteria; data integrity rises on 2026 audit agendas.
- Peptide Degradation in Multi-Active Skin Care: Mechanisms, Case Studies, and Mitigation Protocols
Technical review of peptide degradation in multi-active formulas and proven mitigation steps.
- Scalp Serums Adopt Low-MW Peptides; Suppliers Publish pH Compatibility Data
Scalp serums drive adoption of hydrophilic peptides; suppliers release compatibility data.
- Asia-Pacific SPPS Installations Add Cosmetic Peptide Throughput for 2025–2026
Asia-Pacific SPPS additions shorten cosmetic peptide lead times while raising validation expectations.
- Copper Tripeptide GHK-Cu: Market Dynamics, Specification Trends, and Formulation Integration
An analysis of GHK-Cu demand, tightening COA specs, and formulation best practices in 2025.
- ICPEWG Publishes Updated Guidance on Cosmetic Peptide Impurity Reporting
ICPEWG updates guidance on how cosmetic peptide impurities should be reported on COAs.